<SEC-DOCUMENT>0001683168-23-007106-index.html : 20231012
<SEC-HEADER>0001683168-23-007106.hdr.sgml : 20231012
<ACCEPTANCE-DATETIME>20231012180006
ACCESSION NUMBER:		0001683168-23-007106
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230921
FILED AS OF DATE:		20231012
DATE AS OF CHANGE:		20231012

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Andraczke Andrzej
		CENTRAL INDEX KEY:			0001792732

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39126
		FILM NUMBER:		231323505

	MAIL ADDRESS:	
		STREET 1:		C/O CNS PHARMACEUTICALS, INC.
		STREET 2:		2100 WEST LOOP SOUTH STE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CNS Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001729427
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				822318545
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2100 WEST LOOP SOUTH
		STREET 2:		SUITE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027
		BUSINESS PHONE:		1-800-946-9185

	MAIL ADDRESS:	
		STREET 1:		2100 WEST LOOP SOUTH
		STREET 2:		SUITE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>